AIRS

AirSculpt Technologies, Inc. (AIRS) | Rumor.io

AirSculpt Technologies

AIRS

Attention (50-day avg)0%

Attention rank (50-day avg)#2,287

Bullish sentiment (50-day avg)79%

Price to earnings ratio197

Market capitalization135.5M

Earnings per share-0.18

Dividend yield (TTM)—

Revenue (annual)151.8M

Net income (annual)-11.7M

Social

What share of all stock conversation is about AIRS?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% 0	0% +0	0% +0

Aug 10

$AIRS stock tumbled on a revenue miss and weak guidance, with reported GAAP EPS of -$0.02 and revenue of $42.9M, down -2.53% YoY.
The company reaffirmed its full year 2026 revenue at the lower end of its guidance range, and reduced its adjusted EBITDA outlook to $12-$14 million.
The company's process for sculpting flabby skin after weight loss is not effective, and the use of GLP1 for weight loss may be a better alternative.

Generated by AI

Sentiment

Of the messages about AIRS that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	100%	57.14% +32.14	63.41% -31.93	78.31% +19.16
Bearish	0%	42.86% -32.14	36.59% +31.93	21.69% -19.16

Mar 16

$AIRS has a strong potential for a push to $2.80.
The stock has shown resilience, with buyers stepping in on dips and demonstrating real demand.
A significant increase of 60% on lower earnings suggests a strong underlying value in the company.

Generated by AI

Topics

Of the messages about AIRS that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	0%	0%	75%	31.46%
Analysts	0%	0%	0%	23.05%
Technical Analysis	100%	100%	25%	17.76%
Controversies	0%	0%	0%	0%
Earnings	0%	0%	0%	23.99%
Macro	0%	0%	0%	3.74%

Analysts· Nov 23

Morgan Stanley initiates coverage on AirSculpt Technologies with an Overweight rating and a $17 price target.
Raymond James initiates coverage on AirSculpt Technologies with an Outperform rating and a $18 price target.
SVB Leerink initiates coverage on AirSculpt Technologies with an Outperform rating and a $26 price target.

Announcements· Feb 24

AirSculpt Technologies, Inc. (AIRS) is mentioned as a cannabis stock that may be affected by Germany's legalization of marijuana possession.
The news could potentially impact the stock price of AIRS, but the post does not provide a specific prediction or analysis.
The post is primarily a news update about the legalization of marijuana in Germany, mentioning AIRS as one of the stocks that may be affected.

Generated by AI

Community

Of the messages about AIRS, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	60%	90.14%	19.03%
Newcomers	100%	40%	9.86%	80.97%

Nov 7

Newcomers are focusing on the short-term volatility of $AIRS, with some noting a potential short squeeze profit taking opportunity.
The Q3 earnings report for AirSculpt Technologies ($AIRS) missed expectations, with a GAAP EPS of -$0.15 and revenue of $35M, missing by $0.12 and $4.8M, respectively.
The earnings results were particularly disappointing, with a 39.257% decline in stock price, and a significant decline in sales and gross income compared to the same period last year.

Generated by AI

News

AirSculpt Technologies: Weakness Extends Into Q3 2026 (NASDAQ:AIRS)

13d agoSeeking Alpha

8 Health Care Stocks Whale Activity In Today’s Session

22d agobenzinga.com

AirSculpt (AIRS) Q2 2026 Earnings Call Transcript

Motley Fool Press Release.

1mo agoThe Globe and Mail

AirSculpt Technologies Relocates Corporate Headquarters to Tampa

Detailed price information for Airsculpt Technologies Inc (AIRS-Q) from The Globe and Mail including charting and trades.

1mo agoThe Globe and Mail

AirSculpt Technologies (AIRS) After Q2 Results Is The Valuation Gap Still Real

AirSculpt Technologies (AIRS) is back in focus after reporting Q2 2026 results that showed slightly lower sales and a wider net loss, while management reaffirmed full year revenue guidance at the lower end of its range. See our latest analysis for AirSculpt Technologies. The Q2 2026 earnings release and reaffirmed revenue outlook have landed after a period of sharp share price swings for AirSculpt Technologies, with the stock up strongly year to date but total shareholder return over the past...

1mo agoYahoo Finance

AirSculpt® Partners with Tiger Aesthetics™ in First National Partnership to Offer alloClae™

AirSculpt®, the leader in minimally invasive body contouring, today announced the first national partnership with Tiger Aesthetics™ for alloClae™, an off-the-shelf structural adipose tissue designed for aesthetic body procedures. Launching in August across select AirSculpt locations, the rollout reflects AirSculpt's commitment to expand availability nationwide by the end of 2026.

1mo agoYahoo Finance

Also Discussed

Investors talking about AIRS also mention

#	Name	Attention
1	Neuronetics Inc.STIM	0%0
2	Decent Holding Inc. Class A Ordinary SharesDXST	0.02%new
3	Flash Sports & Media, Inc.UGRO	0%new
4	SciSparc Ltd.SPRC	0%+0
5	ULY - Urgent.ly Inc. Common Stock	——
6	HCW Biologics Inc.HCWB	0%0
7	PMNT - Perfect Moment Ltd. Common Stock	——
8	Onfolio Holdings, Inc.ONFO	0%-0.05
9	FGI Industries Ltd.FGI	0%0
10	Huachen AI Parking Management Technology Holding Co., Ltd. Class A Ordinary SharesHCAI	0%new

AirSculpt Technologies, Inc.

Healthcare
Medical Care Facilities

AirSculpt Technologies, Inc. is a healthcare services company focused on premium body contouring procedures. Through its AirSculpt® platform, the company offers minimally invasive fat removal and fat transfer treatments designed to sculpt targeted areas of the body while tightening skin. Its service portfolio includes procedures such as Power BBL, Up a Cup, and Hip Flip, which address contouring needs across the breasts, buttocks, hips, and other areas. AirSculpt Technologies operates specialized centers that deliver direct medical procedure services to consumers in the United States, Canada, and the United Kingdom. The company is headquartered in Miami Beach, Florida, and serves a niche segment of the aesthetic medicine market centered on customized, non-surgical body shaping solutions.

Website

Location

2023 West Platt Street

Tampa, FL, 33605

United States

Social

What share of all stock conversation is about AIRS?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% 0	0% +0	0% +0

Aug 10

$AIRS stock tumbled on a revenue miss and weak guidance, with reported GAAP EPS of -$0.02 and revenue of $42.9M, down -2.53% YoY.
The company reaffirmed its full year 2026 revenue at the lower end of its guidance range, and reduced its adjusted EBITDA outlook to $12-$14 million.
The company's process for sculpting flabby skin after weight loss is not effective, and the use of GLP1 for weight loss may be a better alternative.

Generated by AI

Sentiment

Of the messages about AIRS that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	100%	57.14% +32.14	63.41% -31.93	78.31% +19.16
Bearish	0%	42.86% -32.14	36.59% +31.93	21.69% -19.16

Mar 16

$AIRS has a strong potential for a push to $2.80.
The stock has shown resilience, with buyers stepping in on dips and demonstrating real demand.
A significant increase of 60% on lower earnings suggests a strong underlying value in the company.

Generated by AI

Topics

Of the messages about AIRS that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	0%	0%	75%	31.46%
Analysts	0%	0%	0%	23.05%
Technical Analysis	100%	100%	25%	17.76%
Controversies	0%	0%	0%	0%
Earnings	0%	0%	0%	23.99%
Macro	0%	0%	0%	3.74%

Analysts· Nov 23

Morgan Stanley initiates coverage on AirSculpt Technologies with an Overweight rating and a $17 price target.
Raymond James initiates coverage on AirSculpt Technologies with an Outperform rating and a $18 price target.
SVB Leerink initiates coverage on AirSculpt Technologies with an Outperform rating and a $26 price target.

Announcements· Feb 24

AirSculpt Technologies, Inc. (AIRS) is mentioned as a cannabis stock that may be affected by Germany's legalization of marijuana possession.
The news could potentially impact the stock price of AIRS, but the post does not provide a specific prediction or analysis.
The post is primarily a news update about the legalization of marijuana in Germany, mentioning AIRS as one of the stocks that may be affected.

Generated by AI

Community

Of the messages about AIRS, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	60%	90.14%	19.03%
Newcomers	100%	40%	9.86%	80.97%

Nov 7

Newcomers are focusing on the short-term volatility of $AIRS, with some noting a potential short squeeze profit taking opportunity.
The Q3 earnings report for AirSculpt Technologies ($AIRS) missed expectations, with a GAAP EPS of -$0.15 and revenue of $35M, missing by $0.12 and $4.8M, respectively.
The earnings results were particularly disappointing, with a 39.257% decline in stock price, and a significant decline in sales and gross income compared to the same period last year.

Generated by AI

AirSculpt Technologies

Social

Aug 10

Mar 16

Analysts· Nov 23

Announcements· Feb 24

Nov 7

AirSculpt Technologies: Weakness Extends Into Q3 2026 (NASDAQ:AIRS)

8 Health Care Stocks Whale Activity In Today’s Session

AirSculpt (AIRS) Q2 2026 Earnings Call Transcript

AirSculpt Technologies Relocates Corporate Headquarters to Tampa

AirSculpt Technologies (AIRS) After Q2 Results Is The Valuation Gap Still Real

AirSculpt® Partners with Tiger Aesthetics™ in First National Partnership to Offer alloClae™

Also Discussed

AirSculpt Technologies, Inc.

Company Information

Location

Social

Aug 10

Mar 16

Analysts· Nov 23

Announcements· Feb 24

Nov 7

AirSculpt Technologies: Weakness Extends Into Q3 2026 (NASDAQ:AIRS)

8 Health Care Stocks Whale Activity In Today’s Session

AirSculpt (AIRS) Q2 2026 Earnings Call Transcript

AirSculpt Technologies Relocates Corporate Headquarters to Tampa

AirSculpt Technologies (AIRS) After Q2 Results Is The Valuation Gap Still Real

AirSculpt® Partners with Tiger Aesthetics™ in First National Partnership to Offer alloClae™

Also Discussed